- Events, Presentations and Webcasts
- Repros in the News
- Major Holders
- Analyst Coverage
- SEC Filings
- Corporate Governance
Repros Therapeutics Inc.
$9.30 
0.30 (3.33%)
Nasdaq: RPRX
The names of our directors and executive officers, and certain additional information with respect to each of them, are set forth below.
| Position Held* | Position Held | Percent of Outstanding Shares |
| Efficacy Capital Ltd. | 2,580,013 | 20.2 |
| Visium Asset Management LLC | 1,180,687 | 9.24 |
| Promed Management, Inc. | 663,144 | 5.19 |
| Franklin Advisors, Inc. | 637,000 | 4.99 |
| RA Capital Management LLC | 579,806 | 4.54 |
| Seneca Capital Advisors LLC | 450,300 | 3.53 |
| Vermillion Asset Management LLC | 435,000 | 3.44 |
| Great Point Partners LLC | 280,940 | 2.2 |
| Wall Street Associates LLC | 275,000 | 2.15 |
| Dimensional Fund Advisors, Inc. | 263,243 | 2.06 |
| Barclays Global Investors NA (CA) | 217,697 | 1.7 |
| Joseph S. Podolski | 110,881 | 0.87 |
| DWS Investment GmbH | 106,400 | 0.83 |